Cosopt

DRUG6 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc., West Virginia University, Advanced Glaucoma Specialists, Alcon Research

Conditions

GlaucomaGlaucoma, Open AngleOcular HypertensionOpen Angle GlaucomaOpen-angle Glaucoma

Phase 3

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT

TerminatedNCT00767481

Alcon ResearchGlaucoma, Ocular Hypertension

Start: 2008-10-31End: 2009-02-28Updated: 2012-07-19

Phase 4

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

CompletedNCT00140049

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Glaucoma, Open Angle, Ocular Hypertension

Start: 2005-07-31End: 2006-07-31Target: 238Updated: 2021-02-18

12-Month Stability of Diurnal IOP Control on Cosopt

CompletedNCT00379834

West Virginia UniversityGlaucoma

Start: 2006-09-30End: 2008-04-30Updated: 2015-02-10

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

TerminatedNCT00471068

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2007-03-31Updated: 2012-04-11

Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension

CompletedNCT00761995

Alcon ResearchGlaucoma, Ocular Hypertension

Start: 2009-02-28End: 2010-07-31Updated: 2012-07-18

Unknown Phase

Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.

Advanced Glaucoma SpecialistsOpen Angle Glaucoma

Start: 2006-10-31Target: 30Updated: 2007-03-01